Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study
Titel:
Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study
Auteur:
Bromberg, Jacoline E C Issa, Samar Bakunina, Katerina Minnema, Monique C Seute, Tatjana Durian, Marc Cull, Gavin Schouten, Harry C Stevens, Wendy B C Zijlstra, Josee M Baars, Joke W Nijland, Marcel Mason, Kylie D Beeker, Aart van den Bent, Martin J Beijert, Max Gonzales, Michael de Jong, Daphne Doorduijn, Jeanette K